Systemic Therapy/Standard of Care

DRUG3 trials

Sponsors

Memorial Sloan Kettering Cancer Center, National University Hospital, Singapore, Ming-Yuan Chen

Conditions

Gastric Cancer Stage IVMetastatic Breast CancerMetastatic Non-Small Cell Lung CarcinomaNon Small Cell Lung CancerOligo-metastatic CancerPeritoneal MetastasisTriple Negative Breast Cancer

Phase 2

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

RecruitingNCT03808337

Memorial Sloan Kettering Cancer CenterMetastatic Breast Cancer, Metastatic Non-Small Cell Lung Carcinoma, Non Small Cell Lung Cancer +1

Start: 2019-01-16End: 2027-01-01Target: 145Updated: 2026-02-27

Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)

Not yet recruitingNCT07241715

National University Hospital, SingaporeGastric Cancer Stage IV, Peritoneal Metastasis

Start: 2026-01-31End: 2034-01-31Target: 300Updated: 2025-11-21

Phase 3

Efficacy and Safety of SBRT Combined With Becotatug Vedotin (MRG003) in EGFR-Positive Metastatic Tumor Patients With Oligometastases

RecruitingNCT07481799

Ming-Yuan ChenOligo-metastatic Cancer

Start: 2026-02-06End: 2030-02-28Target: 200Updated: 2026-04-02

Related Papers

Standard maintenance therapy versus local consolidative radiation therapy and standard maintenance therapy in 1–5 sites of oligometastatic non-small cell lung cancer: a study protocol of phase III randomised controlled trial

BMJ Open2021-03-0111 citations